Fetal hemoglobin has a lot of biochemical advantages for fighting sickle-cell disease on its own so this is leveraged in the CRISPR solution - e.g. create more of the cells that inhibit the disease in the first place.

https://en.wikipedia.org/wiki/Fetal_hemoglobin#Treatment_of_...